key: cord-0035111-xvvurqdk authors: Bayona, Jorge Carrillo; Álvarez, Liliana Arias; León, Paulina Ojeda title: Pulmonary Interstitium date: 2013-01-16 journal: Learning Chest Imaging DOI: 10.1007/978-3-642-34147-2_9 sha: ca6fc712ca68b076263ac81588f5b1b880f53dbb doc_id: 35111 cord_uid: xvvurqdk The first step in the radiographic evaluation of interstitial lung disease begins with a fundamental knowledge of the anatomy of the pulmonary interstitium and the different patterns of disruption. The anatomy of the pulmonary interstitium as demonstrated on CT of the chest with high resolution cuts is largely essential to establish the various radiological patterns that define interstitial lung disease such as the tree-in-bud, ground-glass opacity, crazy -paving, etc. A 24-year-old patient with a 24-h history of progressive dyspnea and dry cough, which started after an injection of liquid silicone in the pectoral region. The diagnosis of silicone pulmonary embolism was con fi rmed by the history, alterations in imaging studies, and the fi ndings of a bronchoalveolar lavage (BAL). Liquid silicone is a highly stable polymer, with minimum tissue reaction, widely used in the cosmetic industry. Subcutaneous injection of liquid silicone can be associated to pulmonary embolism. The preferred sites for subcutaneous injection of liquid silicone are the breasts and gluteus. Silicone pulmonary embolism (SPE) after a subcutaneous injection has been associated to the volume injected and to the local massages following the procedure. The mechanism of pulmonary injury in these patients is similar to that described in fatty embolism with alveolar hemorrhage and fat globules in lung microcirculation and macrophages. Sixty percent of the patients with SPE develop acute respiratory distress syndrome (ARDS), and 20 % die due to respiratory insuf fi ciency. All patients with SPE have abnormal chest x-rays with bilateral and peripheral ground-glass opacities, as the characteristic feature. The most frequent HRCT abnormality in these patients is the presence of bilateral subpleural ground-glass opacities. Other fi ndings in HRCT include thickening of interlobular septum and subpleural reticulation. CT scan shows breast enlargement in male patient with increased density and nodular appearance of subcutaneous fat. Left axillary lymphadenopathy ( Fig. 9 A 16-year-old patient with repeated episodes of cough and dyspnea, which subsided spontaneously. There was a history of occasional contact with pigeons. The diagnosis of hypersensitivity pneumonitis was con fi rmed by the clinical fi ndings, diagnostic images, and BAL fi ndings. Hypersensitivity pneumonitis (HN) is a pulmonary disease with symptoms of cough and dyspnea, produced by the inhalation of an allergen by a previously sensitized individual. Most antigens related with HN originate in bacteria ( Saccharopolyspora rectivirgula ), mold ( Penicillium species), yeast, or poultry (pigeon proteins). Chemical agents such as isocyanates, zinc, tinctures, and dyes can act as haptens to induce NH. In a study carried out in three European countries, HN represented between 4 and 15 % of pulmonary interstitial diseases. HN has traditionally been classi fi ed in acute, subacute, and chronic. However, recent trials by the HN study group have had dif fi culties classifying patients in these groups and particularly in cases previously described as subacute. In the acute phase, radiological abnormalities are similar to those described in pulmonary edema, with multilobar areas of consolidation. In the subacute phase, the main HRCT manifestations are: centrilobular nodule (ill de fi ned), areas of ground-glass opacity (variable distribution and extension), and cystic lesions in 13 % of the cases. In the chronic phase, changes associated to pulmonary fi brosis are found, usually respecting lung bases, with reticular opacities, traction bronchiectasis, and limited areas of honeycombing. A 23-year-old patient with acute chest pain (4 h before consulting the emergency room) and a 1-month history of dry cough and progressive dyspnea. The diagnosis or P . jiroveci pneumonia was con fi rmed by bronchoalveolar lavage. P . jiroveci pneumonia (PJP) has been described in immunocompromised patients and particularly in patients with human immunode fi ciency virus (HIV) infection. The current incidence of PCP in HIV (+) patients has decreased due to the use of high impact antiretroviral therapy and prophylaxis with trimethoprim/sulfamethoxazole. Nevertheless, PJP incidence remains high in HIV (+) patients in underdeveloped countries. The clinical picture of PJP in HIV (+) patients is subacute and characterized by dry cough and progressive dyspnea (2-4 weeks). Radiologic manifestations of P . jiroveci pneumonia include: predominantly central reticular opacities, ground-glass opacities, and mixed opacities. In HRCT, the predominant manifestation is the presence of ground-glass opacities with diverse distributions: central, in a "mosaic" pattern, or diffuse. As the infection progresses, areas of consolidation and reticular opacities may appear. The presence of cystic lesions in PJP is variable according to the series (10-20 % of patients). Cysts appear mainly in apical segments; have variable sizes, irregular margins, and thin or thick walls; and are associated with spontaneous pneumothorax. HRCT shows thin-walled cystic appearance lesions without communication with airway. Peribronchial consolidation adjacent cystic lesions. Right pneumothorax. Upper lobes predominance of cystic appearance lesions (Figs. 9.4.1 , 9.4.2 , and 9.4 A 32-year-old patient with a 6-month history of episodic productive cough with mucoid sputum and dyspnea. Eosinophilia was found in BAL and the diagnosis of chronic eosinophilic pneumonia was con fi rmed by open lung biopsy. Chronic eosinophilic pneumonia (CEP) is an uncommon idiopathic disorder characterized by subacute or chronic respiratory and systemic symptoms, blood and/or alveolar eosinophilia, and peripheral opacities in the chest x-ray. CEN is considered to represent between 0 and 2.5 % of pulmonary interstitial disease cases. This disorder is more frequent in women (2:1) and between one-third and half of the patients with CEP have a history of asthma. Most CEP patients are symptomatic and the most frequent manifestations are: progressive dyspnea, cough, and general symptoms (asthenia, weight loss, and night sweats). Eosinophilia is found in BAL (12-95 % of cellular count, with an average of 59 %). Lung biopsy shows evidence of predominantly eosinophilic alveolar and interstitial in fl ammatory in fi ltration. The classic radiographic fi nding is the "inverse pulmonary edema" (peripheral, mainly apical, nonsegmental consolidation). However, this fi nding is seen in less than 50 % of the patients. HRCT manifestations are variable and related to disease evolution. Predominantly peripheral areas of ground-glass opacities and/or consolidation are more common in early stages. With disease progression, septal lines, reticular opacities, nodules, and subpleural parenchymal bands may be found. A 40-year-old patient with progressive dyspnea starting 6 months before and a history of smoking. The diagnosis of Langerhans cell histiocytosis was made by an open lung biopsy. Pulmonary Langerhans cell histiocytosis (PLCH) is an isolated form of Langerhans cell histiocytosis (LCH) that mainly affects smokers. Disease pathogenesis remains uncertain. LCH represents a clonal proliferation of cells similar to that typical of neoplastic diseases. In the particular case of the pulmonary type, pathogenesis may be different, as it has been demonstrated that most nodules do not follow clonal proliferation. It has been suggested that this disorder corresponds to an exaggerated immune response to an antigen, in which Langerhans cells can serve as accessory cells in T lymphocyte activation. From the histological viewpoint, histiocytosis is a temporary heterogeneous disorder characterized by peribronchiolar proliferation of Langerhans cells, which form nodules. Nodular lesions frequently cavitate forming thick-or thinwalled cysts according to the evolutional stage. These cysts represent the lumen of the dilated airway. In the most severe cases, the presence of fi brosis can reach the alveolar wall, forming scars and distorting pulmonary architecture. It is a clinically rare disease (5 % of interstitial diseases). Patients are sometimes asymptomatic. However, the most frequent symptoms are cough and dyspnea. Other clinical manifestations can be hemoptysis, fever, weight loss, and night sweats. Pneumothorax, sometimes recurrent, can occur in one out of every four patients. Radiological manifestations depend on the evolution of the disease. Chest x-rays can be interpreted as normal in early stages of disease. In advanced cases, the most frequent semiological fi ndings are reticular opacities corresponding to the visualization of the walls of contiguous cystic lesions and predominantly apical small nodules. In HRCT, the most frequent manifestation of early disease is the presence of small, irregular, peribronchiolar nodules, with different degrees of cavitation in an otherwise healthy lung. With disease progression, cystic lesions increase in number and size and their walls become thinner. The presence of cystic lesions larger than 1 cm, with irregular margins, and distortion of pulmonary architecture suggests an advanced stage of the disease. Related fi ndings include ground-glass opacities and changes due to emphysema associated to the habit of smoking. CRX fi lm shows ill-de fi ned nodular opacities (arrows). Peribronchial thickening (Fig. 9.6.1 ) . CT scan shows ground-glass small nodules (black arrows) and soft tissue nodules (arrowheads), with varying degree of cavitation (white arrows) and random distribution (Figs. 9.6.2 and 9.6.3 ). Lung biopsy shows the typical nuclear and cytoplasmic staining of Langerhans cells (S-100 stain, 40×; Fig. 9.6.4 ) . Case 7: Lymphocytic Interstitial Pneumonia A 43-year-old patient with a 1-year clinical picture consisting of cough and dyspnea and a 3-month history of weight loss and fever. After an open lung biopsy, the diagnosis of lymphocytic interstitial pneumonia was made. Lymphocytic interstitial pneumonia (LIP) is considered a nonneoplastic in fl ammatory reaction of bronchial associated lymphoid tissue (BALT). This pattern of pulmonary response can be associated to systemic diseases (Sjögren syndrome, systemic lupus erythematosus), dysproteinemias, human immunode fi ciency virus infection, and adverse reaction to drugs (diphenylhydantoin). In its idiopathic presentation, it is included in the group of idiopathic interstitial pneumonias, due to the presence of fi brosis during the course of the disease in some patients. LIP may appear in pediatric population associated to HIV infection. Most adults with LIP are women between the 5th and 7th decades of life. Clinical manifestations are nonspeci fi c and include cough and dyspnea of gradual onset. Less frequently, weight loss, chest pain, fever, and arthralgia are described. Histologically, LIP is characterized by a lymphocitary in fi ltrate extensively compromising alveolar septa. Hyperplasia of type II pneumocytes and granuloma formation are described. Immunohistochemistry using CD20 shows that B cells are predominantly located in germ centers. Radiological fi ndings described in LIP are nonspeci fi c, with predominantly basal reticular or reticulonodular opacities as the main manifestations. Areas of consolidation and ill-de fi ned nodules may also be found. The most frequent alterations found in HRCT are ground-glass opacities, centrilobular nodules, thickening of peribronchovascular interstitium, interlobular septum thickening, areas of consolidation, and cysts. Pathogenesis of cysts is related to partial obstruction of bronchioles and air trapping due to peribronchial lymphocytic in fi ltration and occasionally due to focal amyloid deposits. Chest x-ray fi lm shows ill-de fi ned nodules (arrow) and ground-glass patchy areas. Thin-walled cystic appearance lesion in right lower lobe (arrowhead) (Fig. 9.7 .1 ). HRCT shows soft tissue nodules and diffuse ground-glass and thin-walled cystic lesions of variable size (Figs. 9.7.2 and 9.7. 3 ). This photomicrograph shows the typical densely cellular appearance of widened alveolar septa (HE stain, 10×; Fig. 9 .7.4 ). A 16-year-old patient with acute lymphocytic leukemia under treatment and a 6-day history of fever, dry cough, and cutaneous vesicular lesions. Considering the clinical picture and imaging study fi ndings, the diagnosis of varicella pneumonia was made. Pneumonia due to Varicella-Zoster virus is the most severe complication of a systemic infection, with a mortality rate ranging between 9 and 50 %. Disease course in children is self-limited and benign. However, in adults, it tends to be a signi fi cant cause of complications. More than 90 % of cases of viral pneumonia due to Varicella-Zoster occur in immunocompromised adult patients and pregnant women. There is no gender predilection. Conditions causing immunosuppression as leukemia, lymphoma, and corticosteroid therapy are considered risk factors. Pregnancy, advanced age, chronic obstructive pulmonary disease, and severe cutaneous eruption are other predisposing conditions. Symptoms of pneumonia develop a few days after cutaneous vesicles appear and include cough, dyspnea, hemoptysis, tachypnea, pleuritic pain, and fever. Histologically, they are nodules formed by areas of hyalinized collagen or necrotic tissue with a fi brous capsule that can resolve and calcify in various ways or form areas of mononuclear in fl ammatory interstitial in fi ltration with an intra-alveolar proteinaceous exudate and hyaline membrane formation (diffuse alveolar damage). Radiological fi ndings include ill-de fi ned nodules, randomly distributed, ranging between 5 and 10 mm in diameter. Nodules can disappear or calcify late after cutaneous lesions have disappeared. Nodular lesions of soft tissue density, ranging between 1 and 10 mm in diameter, which may have a perilesional ground-glass halo, are described in HRCT. Nodular lesions can coalesce and combine with patchy ground-glass opacities. Chest x-ray fi lm shows nodular opacities, ill de fi ned (arrowhead) (Fig. 9.8.1 ). Random soft tissue small nodules with ground-glass halo (Figs. 9.8.2 and 9.8.3 ). Vesicular lesions in the patient's forehead ( Fig. 9.8.4 ). Case 9: Cryptogenic Organizing Pneumonia A 39-year-old patient with a 3-month clinical picture consisting of fever, adynamia, weight loss, and cough. Open lung biopsy was interpreted as a pattern of organizing pneumonia. In the absence of an etiological factor or associated condition, the diagnosis of cryptogenic organizing pneumonia was made. Organizing pneumonia (OP) is a nonspeci fi c histopathological pattern of pulmonary response to injuries of diverse nature, characterized by the presence of granulation tissue buds in the distal airways. This process occurs mainly in alveoli, but may extend to alveolar duct lumen and bronchioles. OP can be classi fi ed in three categories: idiopathic (cryptogenic organizing pneumonia), of known cause (infection, radiation), or of unknown cause associated to a speci fi c clinical context (collagen vascular disease, posttransplant). The histological hallmark of organizing pneumonia is a distinct, usually patchy type of fi brosis that predominantly involves bronchiolar lumen and peribronchiolar airspaces. The fi brosis is composed of elongated fi broblasts and myo fi broblasts arranged in parallel and embedded in a myxoid or pale staining matrix. The typical or classical presentation of OP described in chest x-rays consists of bilateral patchy airspace consolidations, most prominent in the peripheral lower lung zones, with a tendency to progress and change location over time. CT re fl ects the fi ndings of the chest x-ray demonstrating that the areas of consolidation are predominantly peribronchovascular and/or subpleural. Bronchial dilation in consolidated areas is described in 55 % of patients. Other fi ndings in HRCT of patients with OP pattern are: nodule(s) -mass(es), ground-glass opacities, parenchymal bands, nodules with halo and reverse halo signs, and reticular opacities. Chest x-ray fi lm shows consolidation and ground-glass patchy ( Fig. 9 .9.1 ). CT scan (lung window) shows multilobar consolidation and ground-glass halo sign (Figs. 9.9.2 and 9.9.3 ). Lung biopsy shows fi broblast plugs within alveolar spaces (trichrome stain, 10×; Fig. 9 .9.4 ). A 28-year-old female patient with progressive dyspnea and a history of spontaneous pneumothorax. Open lung biopsy showed lymphangioleiomyomatosis. Lymphangioleiomyomatosis (LLM) is a rare, progressive, multisystemic disorder characterized by the proliferation of pulmonary parenchyma bronchiolar, venular, and lymphatic smooth muscle. The pathogenesis is not clearly established but it probably has its bases in TSC2 gene mutations of the tuberous sclerosis complex located in chromosome 16. Although classi fi ed as a different entity, LLM shares its physiopathology with tuberous sclerosis, and LLM patients may have extrapulmonary manifestations such as angiomyolipomas (15-30 % of patients). These similarities lead some researchers to consider LLM as a frustrated form of tuberous sclerosis or that both entities correspond to the same disease with a different degree of expression. LLM affects almost exclusively women of childbearing age and can occur as a complication associated to tuberous sclerosis in women (men with tuberous sclerosis usually do not develop cystic changes of LLM in the lung). Histologically, abnormal proliferation of immature smooth muscle cells within the airway, lymph vessels, and blood vessels causes mechanic obstruction with secondary cyst formation, pneumothorax, lymphatic fl ow obstruction, lymph node enlargement, chylothorax, and pulmonary arterial and venous hypertension that can lead to hemorrhage and hemothorax. A biochemical explanation for cyst formation in this disease is metalloprotease production by LAM cells, which destroy pulmonary collagen and elastin. LAM cells can be identi fi ed by immunohistochemistry techniques that demonstrate the presence of antigens to smooth muscle actin-and melanoma-associated HMB-45. In chest x-rays, the most frequent manifestations are an increase in pulmonary volume and reticular opacities in relation to cyst overlapping. HRCT shows multiple thin-walled cysts, of similar size and regular margins, uniformly distributed in lungs. Lung parenchyma in between cystic lesions is normal. These fi ndings can simulate changes due to emphysema; the diagnostic key relies on the identi fi cation of cyst walls and the population group. Chest x-ray fi lm shows fi ne reticular opacities (Fig. 9.10 .1 ). CT scan (lung window) shows diffuse and uniform small thin-walled cystic lesions ( Fig. 9.10. 2 ). Lung biopsy shows the characteristic smooth muscle in the cyst wall (HE and trichrome stain, 10×; Figs. 9.10.3 and 9.10.4 ). Further Reading Pulmonary alveolar proteinosis Pulmonary alveolar proteinosis: CT fi ndings CT features of pulmonary alveolar proteinosis Crazy-paving appearance at thin-section CT: spectrum of disease and pathologic fi ndings The crazy-paving sign Diseases of the lung: radiologic and pathologic correlations Crazy-paving appearance on high resolution CT in various diseases Pulmonary alveolar proteinosis Silicon emboli syndrome: a sequela of clandestine liquid silicone injections. A case report and review of the literature Thrombotic and nonthrombotic pulmonary arterial embolism: spectrum of imaging fi ndings Nonthrombotic pulmonary embolism Report of a case and review of the literature Massive systemic silicone embolism: a case report and review of literature Silicone pulmonary embolism: report of 10 cases and review of the literature Silicone embolism syndrome Hypersensitivity Pneumonitis Clinical and radiologic manifestations of hypersensitivity pneumonitis Highresolution CT fi ndings of parenchymal fi brosis correlate with prognosis in hypersensitivity pneumonitis Hypersensitivity pneumonitis: correlation of individual CT patterns with functional abnormalities Hypersensitivity pneumonitis: a historical, clinical, and radiologic review Hypersensitivity pneumonitis: sensitivity of high-resolution CT in a population-based study Can CT distinguish hypersensitivity pneumonitis from idiopathic pulmonary fi brosis? The impact and use of high-resolution computed tomography in diffuse lung disease Hypersensitivity pneumonitis: spectrum of high-resolution CT and pathologic fi ndings Chronic hypersensitivity pneumonitis: differentiation from idiopathic pulmonary fi brosis and nonspeci fi c interstitial pneumonia by using thin-section CT The changing face of Pneumocystis carinii pneumonia in AIDS patients Diagnosis of thoracic complications in AIDS: accuracy of CT Accuracy of high-resolution CT in distinguishing between Pneumocystis carinii pneumonia and non-Pneumocystis carinii pneumonia in AIDS patients Pneumocystis jiroveci pneumonia: high-resolution CT fi ndings in patients with and without HIV infection Shortcomings of chest radiography in detecting Pneumocystis carinii pneumonia Interpretation of chest radiographs in AIDS patients: usefulness of CD4 lymphocyte counts Chronic Eosinophilic Pneumonia Chronic eosinophilic pneumonia: evolution of chest radiograms and CT features Pulmonary Interstitium Peripheral opacities in chronic eosinophilic pneumonia: the photographic negative of pulmonary edema Eosinophilic lung diseases: a clinical, radiologic, and pathologic overview Eosinophilic lung diseases: diagnostic accuracy of thin-section CT in 111 patients Chronic eosinophilic pneumonia: CT fi ndings in six cases Pulmonary Langerhans Cell Histiocytosis Pulmonary Langerhans cell histiocytosis: evolution of lesions on CT scans Atypical radiological manifestations of pulmonary Langerhans cell histiocytosis in a 12-year-old girl Pulmonary Langerhans cell histiocytosis Pulmonary histiocytosis X: comparison of radiographic and CT fi ndings Extraosseous Langerhans cell histiocytosis in children Pulmonary Langerhans cell histiocytosis Adult pulmonary Langerhans' cell histiocytosis Adult pulmonary Langerhans' cell histiocytosis Lymphocytic Interstitial Pneumonia Differential diagnosis of lymphocytic interstitial pneumonia and malignant lymphoma on high-resolution CT Lymphocytic interstitial pneumonia: thin-section CT fi ndings in 22 patients Nonspeci fi c interstitial pneumonia with fi brosis: high-resolution CT and pathologic fi ndings Lymphoid interstitial pneumonia: a narrative review Varicella Pneumonia Herpes simplex virus I pneumoniae patterns on CT scans and conventional chest radiographs Imaging of pulmonary viral pneumonia Viral pneumonias in adults: radiologic and pathologic fi ndings CT fi ndings of varicella pneumonia after lung transplantation Herpes simplex virus I pneumonia: conventional chest radiograph pattern Cryptogenic Organizing Pneumonia Organising pneumonia Cryptogenic organizing pneumonia: variety of radiologic fi ndings Cryptogenic organizing pneumonitis. The North American Experience Cryptogenic organizing pneumonia: CT fi ndings in 43 patients Diffuse diseases of the lung: a team approach Organizing pneumonia: perilobular pattern at thin-section CT Lymphangioleiomyomatosis: radiologic-pathologic correlation Imaging features of lymphangioleiomyomatosis: diagnostic pitfalls European Respiratory Society guidelines for the diagnosis and management of lymphangioleiomyomatosis Pulmonary lymphangioleiomyomatosis high-resolution CT fi ndings in 11 patients and compared with the literature